Orphan Drugs in Asia Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market 2011

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Key Pharma News 15 DECEMBER 2014

Key Pharma News 15 DECEMBER 2014

  • $ 1 415
  • Industry report
  • by Espicom Business Intelligence
  • December 2014
  • 29 pages

Industry Trend Analysis - Merck Claims Leadership Of Revived Antibiotics Market With Cubist Acquisition Industry Trend Analysis - Pfizer Will Become Serious Contender In Immuno-Oncology Industry Brief - UCB/Daiichi Sankyo To Jointly Commercialise Lacosamide In Japan Industry Brief - Evotec/Sanofi In ...

Industries: Drug and Medication | Countries: South Korea, United States, Japan, World, Canada, Italy, China, Europe

Cancer Drug News 08 DECEMBER 2014

Cancer Drug News 08 DECEMBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • December 2014
  • 16 pages

Industry Trend Analysis - Rare Diseases Becoming Lucrative Targets Industry Trend Analysis - Neratinib's Delayed Filing Shakes Confidence In Puma Industry Brief - Milestone Triggered As EMA Accepts Application For Imbruvica In WM Industry Brief - FDA Approves Jakafi For Polycythaemia Vera Industry Brief ...

Industries: Drug and Medication | Countries: South Korea, World, China

Korean Drug Co Ltd

Korean Drug Co Ltd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • November 2014
  • 56 pages

A textual analysis of the financial results for Korean Drug Co Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Drug and Medication | Countries: South Korea

JW Pharmaceutical Corporation (001060) - Financial and Strategic SWOT Analysis Review

JW Pharmaceutical Corporation (001060) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

Summary JW Pharmaceutical Corporation (JW Pharmaceutical) is a pharmaceutical company. The company develops, produces and markets analgesics, antipyretics and cold remedy, antidote agents, antimicrobials, anticancer agents, antifungal agents, cardiovascular agents, gastrointestinla agents, miscellaneous, ...

Industries: Drug and Medication | Countries: South Korea

Hepahope Korea, Inc. (Symbol:039350) SWOT Analysis, Strategy, Revenues and Profits

Hepahope Korea, Inc. (Symbol:039350) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Hepahope Korea, Inc. SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: South Korea

Myungmoon pharmaceutical Co.,Ltd. (Symbol:017180) SWOT Analysis, Strategy, Revenues and Profits

Myungmoon pharmaceutical Co.,Ltd. (Symbol:017180) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Myungmoon pharmaceutical Co.,Ltd. SWOT Analysis report provides you ...

Industries: Drug and Medication | Countries: South Korea

Yungjin Pharm Ind. Co., Ltd. (Symbol:003520) SWOT Analysis, Strategy, Revenues and Profits

Yungjin Pharm Ind. Co., Ltd. (Symbol:003520) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Yungjin Pharm Ind. Co., Ltd. SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: South Korea

ChoongAng Vaccine Laboratory (Symbol:072020) SWOT Analysis, Strategy, Revenues and Profits

ChoongAng Vaccine Laboratory (Symbol:072020) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. ChoongAng Vaccine Laboratory SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: South Korea

CrystalGenomics, Inc. (Symbol:083790) SWOT Analysis, Strategy, Revenues and Profits

CrystalGenomics, Inc. (Symbol:083790) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. CrystalGenomics, Inc. SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: South Korea

Daehan New Pharm Co., Ltd. (Symbol:054670) SWOT Analysis, Strategy, Revenues and Profits

Daehan New Pharm Co., Ltd. (Symbol:054670) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Daehan New Pharm Co., Ltd. SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: South Korea

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.